| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 9.500 | 14.271 | 11.246 | 7.263 | 4.858 | 4.852 | 5.317 | 4.852 | - |
| Total Income - EUR | - | 9.500 | 14.271 | 11.246 | 7.263 | 4.858 | 4.852 | 7.280 | 4.852 | - |
| Total Expenses - EUR | - | 606 | 2.008 | 1.072 | 1.812 | 1.501 | 2.539 | 2.369 | 1.913 | - |
| Gross Profit/Loss - EUR | - | 8.893 | 12.263 | 10.174 | 5.451 | 3.357 | 2.313 | 4.911 | 2.939 | - |
| Net Profit/Loss - EUR | - | 8.659 | 11.835 | 9.837 | 5.233 | 3.211 | 2.167 | 4.751 | 2.440 | - |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Dr. Gligă Răzvan Med. Spec. Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 112 | 59 | 16 | 0 | 557 | 363 | 1.078 | 712 | - |
| Current Assets | - | 8.846 | 11.924 | 9.965 | 5.318 | 3.301 | 7.221 | 3.186 | 3.380 | - |
| Inventories | - | 13 | 0 | 32 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | - | 701 | 578 | 455 | 0 | 0 | 0 | 0 | 0 | - |
| Cash | - | 8.132 | 11.346 | 9.478 | 5.318 | 3.301 | 7.221 | 3.186 | 3.380 | - |
| Shareholders Funds | - | 8.703 | 11.887 | 9.888 | 5.284 | 2.954 | 5.056 | 3.773 | 2.686 | - |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | 255 | 95 | 92 | 35 | 903 | 2.527 | 491 | 1.407 | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Gligă Răzvan Med. Spec. Srl